4.5 Article

Animal models for the study of HCV

Journal

CURRENT OPINION IN VIROLOGY
Volume 13, Issue -, Pages 67-74

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.coviro.2015.04.009

Keywords

-

Categories

Funding

  1. Ghent University [01G00507, 01G01712]
  2. Research Foundation Flanders (FWO-Vlaanderen) [1500910N, G0212.10N, G052112N]
  3. Agency for Innovation by Science and Technology (IWT project, HILIM-3D) [140045]
  4. Belgian Federal Government [IUAP P6/36-HEPRO, P7/47-HEPRO-2]
  5. European Union (FP6 HEPACIVAC)
  6. European Union (FP7, HepaMab)
  7. National Institute of Diabetes, Digestive and Kidney Disease [K08DK090576]
  8. Belgian American Educational Foundation

Ask authors/readers for more resources

The development and evaluation of effective therapies and vaccines for the hepatitis C virus (HCV) and the study of its interactions with the mammalian host have been hindered for a long time by the absence of suitable small animal models. Immune compromised mouse models that recapitulate the complete HCV life cycle have been useful to investigate many aspects of the HCV life cycle including antiviral interventions. However, HCV has a high propensity to establish persistence and associated histopathological manifestations such as steatosis, fibrosis, cirrhosis and hepatocellular carcinoma (HCC). Better understanding of these processes requires the development of a permissive and fully immunocompetent small animal model. In this review we summarize the in vivo models that are available for the study of HCV.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Anatomy & Morphology

Screening algorithms for HBV, HCV, HIV and syphilis in an anatomical donation program

Brecht Valcke, Koen Vercauteren, Elizaveta Padalko, Chris Verhofstede, Katharina D'Herde, Wouter Willaert

Summary: This study evaluates screening algorithms for hepatitis B and C virus, HIV, and Treponema pallidum among anatomical donors, with a focus on the impact of postmortem time on hemolysis and its influence on test results and donor discard rate. Early postmortem blood sampling is crucial, as hemolysis can affect certain test results and the allocation of donors.

ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2022)

Article Oncology

Mouse characteristics that affect establishing xenografts from hepatocellular carcinoma patient biopsies in the United States

Chenhui Zou, Imane El Dika, Koen O. A. Vercauteren, Marinela Capanu, Joanne Chou, Jinru Shia, Jill Pilet, Corrine Quirk, Gadi Lalazar, Linda Andrus, Mohammad Kabbani, Amin Yaqubie, Danny Khalil, Taha Mergoub, Luis Chiriboga, Charles M. Rice, Ghassan K. Abou-Alfa, Ype P. de Jong

Summary: The study successfully established PDX models of HCC by implanting biopsy samples under the renal capsule of severely immunodeficient mice, with rising human alpha1-antitrypsin (hAAT) levels used as a marker. This approach showed 57% efficiency in PDX formation, facilitating research into subset-specific HCC more efficiently.

CANCER MEDICINE (2022)

Article Cell Biology

Viral Interference of Hepatitis C and E Virus Replication in Novel Experimental Co-Infection Systems

Thomas Burkard, Nora Proske, Kathrin Resner, Laura Collignon, Leonard Knegendorf, Martina Friesland, Lieven Verhoye, Ibrahim M. Sayed, Yannick Bruggemann, Maximilian K. Nocke, Patrick Behrendt, Heiner Wedemeyer, Philip Meuleman, Daniel Todt, Eike Steinmann

Summary: This study found direct interference between HCV and HEV in human hepatocytes and humanized mice. The protease activity of HCV was found to be linked to this interference. In vivo experiments confirmed that super-infection reduced the replication of both viruses in individual mice.

CELLS (2022)

Article Microbiology

A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo

Christian Heuss, Paul Rothhaar, Rani Burm, Ji-Young Lee, Philipp Ralfs, Uta Haselmann, Luisa J. Stroh, Ombretta Colasanti, Cong Si Tran, Noemi Schafer, Paul Schnitzler, Uta Merle, Ralf Bartenschlager, Arvind H. Patel, Frederik Graw, Thomas Krey, Vibor Laketa, Philip Meuleman, Volker Lohmann

Summary: This study reports an efficient infectious cell culture model for hepatitis C virus (HCV), which can be used for studying infection mechanisms and developing vaccines. The model, generated from a consensus gt1b genome, underwent long-term passaging to adapt and produce high levels of transmissible infectivity. The study's findings are important for understanding the transmission mechanisms of HCV and for research and prevention of HCV.

PLOS PATHOGENS (2022)

Article Gastroenterology & Hepatology

Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections

Rani Burm, Panagiota Maravelia, Gustaf Ahlen, Sandra Ciesek, Noelia Caro Perez, Anna Pasetto, Stephan Urban, Freya Van Houtte, Lieven Verhoye, Heiner Wedemeyer, Magnus Johansson, Lars Frelin, Matti Sallberg, Philip Meuleman

Summary: This study demonstrates the immunogenicity and effectiveness of preS1-HDAg immunotherapy in preventing HBV and HDV infections both in vitro and in vivo. The vaccine can complement current and future therapies for the control of chronic HBV and HDV infection.
Article Gastroenterology & Hepatology

Adeno-associated virus serotype 2 capsid variants for improved liver-directed gene therapy

Nadja Meumann, Marti Cabanes-Creus, Moritz Ertelt, Renina Gale Navarro, Julie Lucifora, Qinggong Yuan, Karin Nien-Huber, Ahmed Abdelrahman, Xuan-Khang Vu, Liang Zhang, Ann-Christin Franke, Christian Schmithals, Albrecht Piiper, Annabelle Vogt, Maria Gonzalez-Carmona, Jochen T. Frueh, Evelyn Ullrich, Philip Meuleman, Steven R. Talbot, Margarete Odenthal, Michael Ott, Erhard Seifried, Clara T. Schoeder, Joachim Schwable, Leszek Lisowski, Hildegard Buning

Summary: This article reports two gene vector variants, MLIV.K and MLIV.A, which were obtained through in vivo AAV peptide display selection in mice. They showed improved hepatocyte targeting and transduction efficiency compared to AAV2 and AAV8, and have potential for liver disease treatment.

HEPATOLOGY (2023)

Article Cell Biology

Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice

Mohammad Kabbani, Eleftherios Michailidis, Sandra Steensels, Clifton G. Fulmer, Joseph M. Luna, Jeremie Le Pen, Matteo Tardelli, Brandon Razooky, Inna Ricardo-Lax, Chenhui Zou, Briana Zeck, Ansgar F. Stenzel, Corrine Quirk, Lander Foquet, Alison W. Ashbrook, William M. Schneider, Serkan Belkaya, Gadi Lalazar, Yupu Liang, Meredith Pittman, Lindsey Devisscher, Hirosh Suemizu, Neil D. Theise, Luis Chiriboga, David E. Cohen, Robert Copenhaver, Markus Grompe, Philip Meuleman, Baran A. Ersoy, Charles M. Rice, Ype P. de Jong

Summary: Research shows that PNPLA3-148M variant in human hepatocytes exacerbates advanced non-alcoholic fatty liver disease (NAFLD). These models will aid in understanding the contribution of human genetic variants to advanced fatty liver diseases.

CELL REPORTS (2022)

Letter Urology & Nephrology

Urethritis Without Skin Lesions as the Primary Manifestation of Mpox Virus Infection

Laurens Liesenborghs, Veerle Huyst, Christophe Van Dijck, Jojanneke Rutgers, Irith De Baetselier, Chris Kenyon, Marjan Van Esbroeck, Koen Vercauteren

EUROPEAN UROLOGY (2023)

Article Virology

Alternative sampling specimens for the molecular detection of mpox (formerly monkeypox) virus

Jasmine Coppens, Fien Vanroye, Isabel Brosius, Laurens Liesenborghs, Saskia van Henten, Thibaut Vanbaelen, Stefanie Bracke, Nicole Berens-Riha, Irith De Baetselier, Chris Kenyon, Patrick Soentjens, Eric Florence, Johan Van Griensven, Kevin K. Arien, Bart K. M. Jacobs, Dorien Van den Bossche, Marjan Van Esbroeck, Koen Vercauteren

Summary: This study verified the value of alternative specimen types, such as oropharyngeal swabs and saliva, for mpox laboratory confirmation. It found that saliva had higher diagnostic sensitivity and MPXV viral loads compared to oropharyngeal swabs and EDTA plasma. The recommendation to collect oropharyngeal swabs for mpox diagnosis may need to be revised to include saliva, and further research is needed to understand the potential role of saliva in disease transmission.

JOURNAL OF CLINICAL VIROLOGY (2023)

Article Infectious Diseases

Understanding sexual transmission dynamics and transmission contexts of monkeypox virus: a mixed-methods study of the early outbreak in Belgium (May-June 2022)

Jef Vanhamel, Valeska Laisnez, Laurens Liesenborghs, Isabel Brosius, Nicole Berens-Riha, Thibaut Vanbaelen, Chris Kenyon, Koen Vercauteren, Marie Laga, Naima Hammami, Oriane Lambricht, Romain Mahieu, Amaryl Lecompte, Wim Vanden Berghe, Bea Vuylsteke

Summary: This study describes the initial phase of the monkeypox outbreak in Belgium and provides a detailed description of sexual behavior and transmission contexts. The results suggest that sexual contact and networks play a significant role in the transmission of monkeypox. Delayed detection of monkeypox infection may be attributed to the confusion of initial symptoms with other sexually transmitted infections or skin conditions, as well as low perception of risk.

SEXUALLY TRANSMITTED INFECTIONS (2023)

Article Virology

Presymptomatic viral shedding in high-risk mpox contacts: A prospective cohort study

Isabel Brosius, Christophe Van Dijck, Jasmine Coppens, Leen Vandenhove, Eugene Bangwen, Fien Vanroye, Jacob Verschueren, Sabine Zange, Joachim Bugert, Johan Michiels, Emmanuel Bottieau, Patrick Soentjens, Johan van Griensven, Chris Kenyon, Kevin Arien, Marjan Van Esbroeck, Koen Vercauteren, Laurens Liesenborghs

Summary: A prospective longitudinal cohort study conducted on high-risk contacts of mpox patients in Antwerp, Belgium revealed that the risk of infection after exposure to clade IIb mpox virus (MPXV) is uncertain, and presymptomatic shedding of MPXV has been established. Out of the included participants, 66.0% of sexual contacts and 14.0% of non-sexual contacts showed evidence of MPXV infection by PCR testing. The study also found cases with typical mpox symptoms and confirmed the existence of presymptomatic shedding of replication-competent MPXV, highlighting the high transmission risk during sexual contact.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Microbiology

Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity

Ole Lagatie, Dax Lauwers, Harvinder Singh, Fien Vanroye, Daniel J. Stieh, Johan Vingerhoets, Ludo Lavreys, Valerie Oriol-Mathieu, Will Colon, Chris Verhofstede, Koen Vercauteren, Dorien Van den Bossche, Maria Grazia Pau

Summary: The use of current serological tests may pose challenges to the adoption of HIV vaccines due to the overlap between HIV antigens detected in these tests and those used in the vaccines. Our study aimed to identify target antigens that can be used in new serological tests to accurately diagnose HIV infections without interference from vaccine-induced antibodies.

MICROBIOLOGY SPECTRUM (2023)

Article Infectious Diseases

Characteristics of confirmed mpox cases among clinical suspects: A prospective single-centre study in Belgium during the 2022 outbreak

Matilde Hens, Isabel Brosius, Nicole Berens-Riha, Jasmine Coppens, Liesbeth Van Gestel, Jojanneke Rutgers, Chris Kenyon, Patrick Soentjens, Saskia van Henten, Stefanie Bracke, Thibaut Vanbaelen, Leen Vandenhoven, Emmanuel Bottieau, Koen Vercauteren, Marjan Van Esbroeck, Laurens Liesenborghs, Christophe Van Dijck

Summary: This study described the characteristics of mpox patients who sought care at a Belgian sexual health clinic and compared them to patients with a clinical suspicion of mpox but tested negative. The presence of skin lesions, lymphadenopathy, and proctitis were associated with the diagnosis of mpox. Age, HIV status, childhood smallpox vaccination, number of sexual partners, and international travel were not associated with mpox.

NEW MICROBES AND NEW INFECTIONS (2023)

Article Gastroenterology & Hepatology

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection

Rani Burm, Freya Van Houtte, Lieven Verhoye, Ahmed Atef Mesalam, Sandra Ciesek, Philippe Roingeard, Heiner Wedemeyer, Geert Leroux-Roels, Philip Meuleman

Summary: This study evaluated a specific antibody against HBV/HDV infection and found that it could prevent infection and reduce viral loads, providing a valuable candidate for the functional cure of chronic HBV and HDV infections.

JHEP REPORTS (2023)

Article Immunology

Diagnosing Viral Infections Through T-Cell Receptor Sequencing of Activated CD8+ T Cells

Alexandra Vujkovic, My Ha, Tessa de Block, Lida van Petersen, Isabel Brosius, Caroline Theunissen, Sabrina H. van Ierssel, Esther Bartholomeus, Wim Adriaensen, Guido Vanham, George Elias, Pierre Van Damme, Viggo Van Tendeloo, Philippe Beutels, Maartje van Frankenhuijsen, Erika Vlieghe, Benson Ogunjimi, Kris Laukens, Pieter Meysman, Koen Vercauteren

Summary: This study demonstrates that annotating TCR sequences of activated CD8+ T cells can be used to diagnose acute viral infections and differentiate them from historical exposures.

JOURNAL OF INFECTIOUS DISEASES (2023)

No Data Available